For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
13
views
0
references
 Top references
cited by
3
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      2,957
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Haematological cancer: Lenalidomide maintenance--perils of a premature denouement.

      Author(s):
      Publication date:
      Journal: Nature reviews. Clinical oncology
      Keywords: Antineoplastic Agents, therapeutic use, Disease Management, Hematologic Diseases, drug therapy, Humans, Randomized Controlled Trials as Topic, Severity of Illness Index, Thalidomide, analogs & derivatives

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          PubMed ID:: 22665364
          DOI:: 10.1038/nrclinonc.2012.100

          ScienceOpen disciplines: Chemistry
          Keywords: Antineoplastic Agents,therapeutic use,Disease Management,Hematologic Diseases,drug therapy,Humans,Randomized Controlled Trials as Topic,Severity of Illness Index,Thalidomide,analogs & derivatives
          Data availability:
          ScienceOpen disciplines: Chemistry
          Keywords: Antineoplastic Agents, therapeutic use, Disease Management, Hematologic Diseases, drug therapy, Humans, Randomized Controlled Trials as Topic, Severity of Illness Index, Thalidomide, analogs & derivatives

          Comments

          Comment on this article